Houssiau FA
Université Catholique de Louvain
H-index: 77
Europe-Belgium
Top articles of Houssiau FA
O39 Immune deposit resorption in per-protocol repeat kidney biopsy performed in patients with proliferative lupus nephritis
2024/3/1
O40 Impact of glucocorticoid dose on complete response, serious infections, and mortality during the initial therapy of lupus nephritis: a systematic review and meta-analysis …
2024/3/1
Flemish network on rare connective tissue diseases (CTD): patient pathways in systemic sclerosis. First steps taken
Acta Clinica Belgica
2024/1/2
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
2010/12/1
Kidney involvement in systemic lupus erythematosus: From the patient assessment to a tailored treatment
2023/12/26
Effect of Belimumab on Preventing de novo Renal Lupus Flares
Kidney international reports
2023/9/1
From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies
2023/8/3
Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial.
2023/8/1
Détection et prise en charge précoce d’une néphrite lupique
2023/7/13
LSO-028 Predictors of de novo renal flares in systemic lupus erythematosus–time to revisit belimumab dose for extra-renal disease? Results from five phase III clinical trials …
2023/7/1
POS1156 PREDICTORS OF DE NOVO RENAL FLARES IN SYSTEMIC LUPUS ERYTHEMATOSUS–TIME TO REVISIT BELIMUMAB DOSE FOR EXTRA-RENAL DISEASE? RESULTS FROM FIVE PHASE III CLINICAL TRIALS …
2023/6/1
De novo renal flares in SLE patients treated for active extra renal disease within five phase Ill clinical trials of belimumab: Implications for revisiting belimumab dose
2023
Innovations 2022 en rhumatologie
Louvain médical
2023
CODEN: BANMA
Bulletin de l'Académie Nationale de Médecine
2022
Actualités dans la néphrite lupique
2022/1/1
From sequential to combination and personalised therapy in lupus nephritis: moving towards a paradigm shift?
Annals of the rheumatic diseases
2022/1/1
Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET
2022/12
New treatment options in lupus nephritis
2022/12
Treat-to-target in lupus nephritis. What is the role of the repeat kidney biopsy?
2022/12
Safety and efficacy of belimumab in patients with lupus nephritis: open-label extension of BLISS-LN study
Clinical journal of the American Society of Nephrology
2022/11/1
